Postoperative Radiotherapy in Pathological T2–3N0M0 Thoracic Esophageal Squamous Cell Carcinoma: Interim Report of a Prospective, Phase III, Randomized Controlled Study
The Oncologist, Volume 25, Issue 4, Page e701-e708, April 2020.
Opioid Prescribing Trends in Women Following Mastectomy or Breast‐Conserving Surgery Before and After the 2014 Federal Reclassification of Hydrocodone
The Oncologist, Volume 25, Issue 4, Page 281-289, April 2020.
Subtype‐Guided 18F‐FDG PET/CT in Tailoring Axillary Surgery Among Patients with Node‐Positive Breast Cancer Treated with Neoadjuvant Chemotherapy: A Feasibility Study
The Oncologist, Volume 25, Issue 4, Page e626-e633, April 2020.
Evaluation of Serious Postmarket Safety Signals Within 2 Years of FDA Approval for New Cancer Drugs
The Oncologist, Volume 25, Issue 4, Page 348-354, April 2020.
Single‐Center Experience with Ifosfamide Monotherapy as Second‐Line Treatment of Recurrent/Metastatic Osteosarcoma
The Oncologist, Volume 25, Issue 4, Page e716-e721, April 2020.
When Cancer Hits the Oncologist's Home
The Oncologist, Volume 25, Issue 4, Page 359-360, April 2020.
Mistaking the Trees for the Forest?
The Oncologist, Volume 25, Issue 4, Page e743-e743, April 2020.
In Reply
The Oncologist, Volume 25, Issue 4, Page e744-e745, April 2020.
Weekly Chemotherapy of 5‐Fluorouracil plus Cisplatin Concurrent with Radiotherapy for Esophageal Squamous Cell Carcinoma Patients with Postoperative Locoregional Recurrence: Results from a Phase II Study
The Oncologist, Volume 25, Issue 4, Page 308-e625, April 2020.
Impact of Onset of Psychiatric Disorders and Psychiatric Treatment on Mortality Among Patients with Cancer
The Oncologist, Volume 25, Issue 4, Page e733-e742, April 2020.
Combined Expression of Plasma Thrombospondin‐2 and CA19‐9 for Diagnosis of Pancreatic Cancer and Distal Cholangiocarcinoma: A Proteome Approach
The Oncologist, Volume 25, Issue 4, Page e634-e643, April 2020.
Second Primary Malignancies in Patients with Colorectal Cancer: A Population‐Based Analysis
The Oncologist, Volume 25, Issue 4, Page e644-e650, April 2020.
The EORTC QLQ‐C30 Summary Score as a Prognostic Factor for Survival of Patients with Cancer: A Commentary
The Oncologist, Volume 25, Issue 4, Page e610-e611, April 2020.
Comparative Effectiveness of Palliative Chemotherapy in Metastatic Breast Cancer: A Real‐World Evidence Analysis
The Oncologist, Volume 25, Issue 4, Page 319-326, April 2020.
Leveraging the Potential Synergy Between Patient‐Reported Outcomes and Body Composition Analysis in Patients with Cancer
The Oncologist, Volume 25, Issue 4, Page 271-273, April 2020.
Clinicopathological Features Predict Outcomes in Patients with Radioiodine‐Refractory Differentiated Thyroid Cancer Treated with Sorafenib: A Real‐World Study
The Oncologist, Volume 25, Issue 4, Page e668-e678, April 2020.
Treatment Patterns and Health Resource Use Among Patients with Metastatic Gastroenteropancreatic Neuroendocrine Tumors Treated at a Tertiary Referral Center
The Oncologist, Volume 25, Issue 4, Page e644-e650, April 2020.
Drug Shortages: The View Across an Ocean
The Oncologist, Volume 25, Issue 4, Page 274-276, April 2020.
Challenges Conveying Clinical Equipoise and Exploring Patient Treatment Preferences in an Oncology Trial Comparing Active Monitoring with Radiotherapy (ROAM/EORTC 1308)
The Oncologist, Volume 25, Issue 4, Page e691-e700, April 2020.
EMA Review of Daunorubicin and Cytarabine Encapsulated in Liposomes (Vyxeos, CPX‐351) for the Treatment of Adults with Newly Diagnosed, Therapy‐Related Acute Myeloid Leukemia or Acute Myeloid Leukemia with Myelodysplasia‐Related Changes
The Oncologist, EarlyView.
Table of Contents for The Oncologist. List of articles from both the latest and EarlyView issues.
Subscribe to Early View from The Oncologist feed